Vilket är priset för AXIM Biotechnologies, Inc. (AXIM)

Priset för AXIM Biotechnologies, Inc. (AXIM) är $0.0046

Vilket är marknadsvärdet för AXIM Biotechnologies, Inc. (AXIM)

Marknadsvärdet för AXIM Biotechnologies, Inc. (AXIM) är $1.57M

AXIM Biotechnologies, Inc. (AXIM) P/E-tal

AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.

År	P/E-tal	Ändra
Inte tillräckligt med data för de angivna datumen.

År

P/E-tal

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	P/E-tal	Skillnad i P/E-tal	Land
Vertex Pharmaceuticals Incorporated VRTX.US	28.05	-	US
Argenx SE ARGX.US	31.14	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	19.30	-	BE

Företag

P/E-tal

Skillnad i P/E-tal

Land